title: Usefulness of maternal red cell antibodies to predict hemolytic disease of the fetus and newborn and significant neonatal hyperbilirubinemia: a retrospective study.
authors.affiliation: .
authors.forename: Bart
authors.initials: B
authors.lastname: Peeters
authors.affiliation: .
authors.forename: Inge
authors.initials: I
authors.lastname: Geerts
authors.affiliation: .
authors.forename: Anne-Mie
authors.initials: AM
authors.lastname: Badts
authors.affiliation: .
authors.forename: Veroniek
authors.initials: V
authors.lastname: Saegeman
authors.affiliation: .
authors.forename: Jan
authors.initials: J
authors.lastname: Moerman
mesh_terms: D004912:Erythrocytes / Q000276:immunology*; D005312:Fetal Blood / Q000378:metabolism; D006801:Humans; D051556:Hyperbilirubinemia, Neonatal / Q000175:diagnosis* / Q000453:epidemiology; D007231:Infant, Newborn; D011296:Prenatal Diagnosis; D015995:Prevalence; D012189:Retrospective Studies; D018029:Rho(D) Immune Globulin / Q000097:blood*
chemical_list: C061961:RHO(D) antibody; D018029:Rho(D) Immune Globulin
keywords: alloimmunisation in pregnancy; hemolytic disease of the fetus and newborn; prevalence of maternal erythrocyte antibodies